NiSource Inc. (NI) Guidance & Earnings Results
On 2026-08-05 NiSource Inc. reaffirmed guidance: "FY2026 non-GAAP consolidated adjusted EPS guidance $2.02-$2.07; 2026-2033 CAGR 9%-10%; 2026-2030 capex $28.6B ($21.0B base + $7.6B data…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NINiSource Inc.Follow NI — free
—
Price chart with a free account
- Market cap
- 20.8B
- P/E TTM
- 23.0
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Reaffirmed | FY2026 non-GAAP consolidated adjusted EPS guidance $2.02-$2.07; 2026-2033 CAGR 9%-10%; 2026-2030 capex $28.6B ($21.0B base + $7.6B data center) · full year |
| 6 May 26 | Raised | FY2026 non-GAAP consolidated adjusted EPS guidance reaffirmed $2.02-$2.07; long-term CAGR raised to 9%-10% from 2026-2033 (previously 6%-8%) · full year |
| 11 Feb 26 | Raised | FY2025 non-GAAP adjusted EPS above guidance range; FY2026 guidance $2.02-$2.07 reaffirmed; 8%-9% CAGR through 2033. · full year |
| 29 Oct 25 | Raised | FY2025 guidance reaffirmed to upper half ($1.85-$1.89); FY2026 introduced ($2.02-$2.07); base plan growth 6%-8% extended to 2030; consolidated CAGR 8%-9% through 2033. · full year |
| 6 Aug 25 | Reaffirmed | FY25 non-GAAP adjusted EPS guidance narrowed to upper half of $1.85-$1.89; FY25-29 annual adjusted EPS growth 6%-8%; FY25-29 capex $19.4B; annual rate base growth 8%-10% · full year |
NiSource Inc. — questions
- What guidance did NiSource Inc. give?
- On 2026-08-05: "FY2026 non-GAAP consolidated adjusted EPS guidance $2.02-$2.07; 2026-2033 CAGR 9%-10%; 2026-2030 capex $28.6B ($21.0B base + $7.6B data center)"
- When does NiSource Inc. report earnings?
- NiSource Inc.'s next earnings report is expected on 2026-10-28.
Every figure on this page comes from NiSource Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.